Stocktoria
VASO Corp VASO
VASO Corp (VASO) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $89.1M at a 1.8% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Manufacturing · percentile among 1829 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.246 |
| Retained earnings / assets | -0.368 |
| EBIT / assets | -0.033 |
| Equity / liabilities | 0.499 |
Detailed pages
Sector peers · similar-size Manufacturing companies
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| VASO | VASO Corp | 6/9 | 0.72 | 21.3 | +2.7% |
| CBLL | Ceribell, Inc. | 3/9 | 3.97 | — | +36.1% |
| BLFS | BIOLIFE SOLUTIONS INC | 6/9 | 10.32 | — | +28.9% |
| FOCL | EDAP TMS SA | 3/9 | -5.4 | — | +1.6% |
| ELMD | Electromed, Inc. | 6/9 | 10.99 | 46.4 | +17% |
| OM | Outset Medical, Inc. | 6/9 | -9.87 | — | +5.1% |
| IRIX | IRIDEX CORP | 4/9 | -8.01 | — | +8.2% |
FAQ
Is VASO financially healthy?
VASO Corp's Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does VASO pay a dividend?
No, VASO Corp does not currently pay a dividend.
How profitable is VASO?
In FY2025, VASO Corp had a net margin of 1.8% and a return on equity of 5.3%.
Source: SEC EDGAR filings · CIK 0000839087 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.